Afleveringen
-
ALL EPISODES AS VIDEOhttps://youtu.be/La-723RhDIACONNECT WITH UShttps://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan
-
FOLLOW MLLTwitter: @leukaemielabormll.com
-
Zijn er afleveringen die ontbreken?
-
FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan
-
https://twitter.com/AbbasiMuqtadir
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
-
Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell therapy to treat cancers of the blood, including Non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma. Her focus is in the development of phase I clinical trials. She is also interested in patient safety, particularly in optimizing patient safety for cellular immunotherapies.
Nico Gagelmann and Jennifer Brudno
ALL EPISODES AS AUDIO
APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846
SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab
GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
-
Cindy Chmielewski (@myelomateacher on Twitter) was diagnosed with multiple myeloma in July 2008 after suffering for two years with debilitating back pain which was wrongly attributed to degenerative disc disease.
ALL EPISODES AS AUDIO
APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846
SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab
GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
CONNECT WITH MYELOMA ADVOCATES
https://healthtree.org/myeloma -
Heslop is a professor of medicine and pediatrics and holds the Dan L Duncan Chair at Baylor. She is a physician-scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells to improve hemopoietic stem cell transplantation and cancer therapy. She has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently holds more than 20 Investigational New Drug Applications. She also has played a major role nationally as president of societies focusing on the intellectual and clinical development of cellular therapies and accreditation of facilities delivering cell therapies. Dr. Helen Heslop has been elected to the National Academy of Medicine. She is among 90 regular members and 10 international members announced today at the Academy’s annual meeting.
-
Dr. Mohyuddin completed his medical training at Aga Khan University in Pakistan and his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. He completed his fellowship developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods end of life, cost-effective/evidence based care and medical education. He enjoys the outdoors, and that drew him to life in Utah where he is currently Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.
-
Nikita Mehra (@DrNikitaMehra) is an Associate Professor at Medical Oncology and Researcher in Molecular Oncology in the Cancer Institute (WIA), Chennai, India.
-
Dr. Raffaella Greco (@RaffaellaGrecoM) is a hematologist in the Department of Hematology and Bone Marrow Transplantation at the IRCCS Ospedale San Raffaele under the supervision of Professor Fabio Ciceri. After graduating in 2008 from the Faculty of Medicine and Surgery of the University of Milan Vita-Salute San Raffaele received a specialization in hematology at the same university in 2014.
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
-
Final year hematology fellow: @nihardesai7
Interview: Nico Gagelmann, Claire Horgan
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
-
Anna Sureda is president elect of EBMT
-
https://www.uicc.org/membership/national-cancer-institute-kiev-ukraine
-
Assistant Professor, Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Interview: Nico Gagelmann, Claire Horgan
-
Dr Toby Eyre is a substantive consultant haematologist at Oxford University Hospitals NHS Foundation Trust specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia. Twitter: https://twitter.com/TobyEyre82 Interview: Nico Gagelmann
-
Dr. Birhiray earned a Doctor of Medicine degree from the University of Benin, Nigeria, and completed his Internal Medicine residency at Columbus Hospital (an affiliate of Northwestern University) in Chicago, Illinois. He completed fellowships in Bone Marrow Transplant and Medical Oncology at Johns Hopkins University and The National Cancer Institute in Bethesda, Maryland, respectively. Dr. Birhiray has participated in research and is published on the subjects of immunotherapy, lymphomas and bone marrow transplantation. Dr. Birhiray is a member of The American Society of Clinical Oncology, American Society of Hematology, American Medical Association and the Wisconsin Medical Society. Interview: Nico Gagelmann and Claire Horgan
-
The following podcast hosts trainees from Latina America, Laura Saavedra from Venezuela, Andres Gomez from Mexico, Rafaela Muratori from Brazil and Susy Bazan from Peru. This recording is the second part, where we discuss shared experiences and challenges. But most of the time, we will listen to them and learn from them. The first part with presentations of each country can be found on our youtube channel: https://youtu.be/fJmv5glG1sY
-
The following is a conversation with Prof Nada Hamad, a senior staff specialist in bone marrow transplant, clinical and laboratory haematologist at St Vincent’s hospital in Sydney, where she is also director of the haematology clinical trials unit. She is President of the Bone Marrow Transplant Society of Australia and New Zealand. She is a senior lecturer at the University of Sydney and University of NSW.
-
The following is a conversation with Prof Vincent Rajkumar is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. Dr. Rajkumar served as the principal investigator on several clinical trials for the treatment of myeloma. We talk with him about myeloma, COVID, how he thinks trainees can make sense of all the data out there, access to treatments and drug costs.
Interview: Nico Gagelmann, Claire Horgan
-
This conversation is about cancer and all the overwhelming challenges and potential discrimination that come with the diagnosis, inequalities, death, the impact of COVID, the importance of time and communication, and Chris' unique and inspiring story.
His website: www.chris-cancercommunity.com
SimPal: https://www.yoursimpal.com/
Interview: Nico Gagelmann
- Laat meer zien